glp-1 for ibs-d TrimRX GLP-1 Medications & Your Gut:

Zhang Y, Tang C, He Y, Zhang Y, Li Q, Zhang T, Zhao B, Tong A, Zhong Q, Zhong Z (2024) Semaglutide ameliorates Alzheimers disease and restores oxytocin in APP/PS1 mice and human brain organoid models

Second, the off-label adoption pattern that the longevity reframing will inevitably accelerate is going to produce the next wave of monitoring, dosing, and selection problems, patients without obesity or diabetes do not have the diagnostic anchors (BMI, A1c, insulin resistance markers) that frame the on-label conversation, and the clinical infrastructure for managing GLP-1 therapy in metabolically healthy users is, charitably described, thin

Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity

Improves Insulin Sensitivity MOTS-C significantly improves how your cells respond to insulin, which: Lowers blood sugar levels Reduces insulin requirements Decreases fat storage Prevents or reverses type 2 diabetes Reduces cardiovascular disease risk In research studies, MOTS-C treatment reversed high-fat diet-induced insulin resistance and improved glucose metabolism even in already diabetic animals